(GILD) Gilead Sciences, Inc.

Ashton Cal 2015-08-24

Views 2

(GILD) Gilead Sciences, Inc.
Show more

Share This Video


Download

  
Report form
RELATED VIDEOS
Gilead Sciences, Pharmactive İlaç ile yerli üretim anlaşması imzaladı (2) - İSTANBUL
play
05:36

Gilead Sciences, Pharmactive İlaç ile yerli üretim anlaşması imzaladı (2) - İSTANBUL
Gilead Sciences Inc’s antiviral remdesivir could be priced up to $5,080 per course
play
03:10

Gilead Sciences Inc’s antiviral remdesivir could be priced up to $5,080 per course
Ricerca, premiati a Milano i vincitori della 13esima edizione dei Bandi di Gilead Sciences
play
03:20

Ricerca, premiati a Milano i vincitori della 13esima edizione dei Bandi di Gilead Sciences
Gilead Sciences, Panera Bread, Apple: Stock Market Movers
play
01:14

Gilead Sciences, Panera Bread, Apple: Stock Market Movers
Al via la campagna di sensibilizzazione ‘Hiv. Ne parliamo?’ di Gilead Sciences
play
02:29

Al via la campagna di sensibilizzazione ‘Hiv. Ne parliamo?’ di Gilead Sciences
Aids, Da Silva (Gilead Sciences):
play
01:22

Aids, Da Silva (Gilead Sciences): "Molti progressi, ma c’è tanta disinformazione"
Scores Equity GPS: la valeur Gilead Sciences rafle un 10 sur 10: Gilles Bazy-Sire, dans Intégrale Bourse – 19/08
play
07:53

Scores Equity GPS: la valeur Gilead Sciences rafle un 10 sur 10: Gilles Bazy-Sire, dans Intégrale Bourse – 19/08
Gilead Sciences Could Catapult This Company To Profitability
play
06:19

Gilead Sciences Could Catapult This Company To Profitability
U.S. FDA gives full approval to Gilead Sciences' antivirul drug Remdesivir as COVID-19 treatment
play
02:22

U.S. FDA gives full approval to Gilead Sciences' antivirul drug Remdesivir as COVID-19 treatment
U.S. FDA gives full approval to Gilead Sciences' antivirul drug Remdesivir as COVID-19 treatment
play
00:35

U.S. FDA gives full approval to Gilead Sciences' antivirul drug Remdesivir as COVID-19 treatment
Tumore, da Silva (Gilead Sciences):
play
00:52

Tumore, da Silva (Gilead Sciences): "Onorati di essere al fianco di Aiom"
COVID-19 Updates | For Easy Access of Remdesivir, India Asked to Revoke Gilead Sciences' Patents
play
06:30

COVID-19 Updates | For Easy Access of Remdesivir, India Asked to Revoke Gilead Sciences' Patents